Recently, China Zhongji invested in Nanjing Perlove Medical Equipment Co., Ltd. (referred to as " Perlove Medical"). After this round of financing, Perlove Medical will choose to launch the SSE STAR Market listing plan.

Perlove Medical was founded in 2003, which is a high-tech company featured with imaging equipment R&D, production, sales and after-sales service. Headquartered in Nanjing, the sales network spread all over the world and the products are widely exported to five continents, more than 200 countries and regions.

Yang Xiaoying, partner and managing director of China Zhongji Investment, said that the current structure of China's medical imaging equipment market is unbalanced, and there is a lot of domestic substitute space for high-end products. Perlove Medical insists on independent research and development, possesses patented core technology in many key links, and has a layout in high-end products. Several products have been approved by many Grade III Level A hospitals, and are fully prepared for future production capacity. The company's further development and growth has laid a good foundation. We look forward to Perlove Medical's continued use of product technology advantages and accelerated growth with the help of capital. China Zhongji will also continue to pay attention to investment opportunities in the medical industry, and look forward to cooperating with more outstanding enterprises and institutions to promote industrial development.